In a surprise move Thursday, Neumora remade its executive team and brought back its former CEO, following last month's ...

A series of actions by President Donald Trump's administration have provoked profound anxiety among academic labs that ...

Agios' Pyrukynd met primary endpoint in Phase 3 study for children with PK deficiency who don't need regular transfusions, ...

Sanofi faces $250M charge after E. coli vaccine developed with J&J fails Phase 3 trial; study ends early due to insufficient ...

Knownwell expands with 6 new Chicago locations, adding to existing Boston and Dallas clinics. CEO reports 78% virtual visits.

Idorsia’s plan to hand over the global rights to its blood pressure drug Tryvio has ended in disappointment after a deal announced in November fell through.

Newleos Therapeutics emerged Thursday with $93.5 million and a bundle of oral small molecules that it licensed from Roche, ...

The Senate on Thursday confirmed Robert F. Kennedy Jr. as secretary of Health and Human Services, putting a longtime ...

CVS Health ended 2024 as it started, with high medical costs in the company’s insurance business chipping away at its bottom ...

After quickly enrolling its pivotal trial and recruiting more patients with a rare muscle disease than anticipated, Abcuro ...

Cerula Care raises $3.7M seed round to support cancer patients' mental health between appointments, selling directly to ...

CMO Dietmar Berger leads Gilead's R&D efforts with 54 clinical programs, anticipating Sunlenca's HIV PrEP launch & touting no ...